GPT Healthcare Limited has informed the Exchange regarding a press release dated August 06, 2025, titled "GPTHEALTH Reports Results for the First Quarter ended on June 25".
GPTHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GPT Healthcare reported Q1 FY26 (quarter ended June 30, 2025) results with total income rising 8.6% year-on-year to Rs. 108.7 crores and revenue from operations up 9.5% to Rs. 107.1 crores. However, profitability declined — EBITDA fell to Rs. 18.9 crores (margin 17.4%, down from 20.2%) and net profit dropped to Rs. 7.7 crores (PAT margin 7.1%, down from Rs. 9.9 crores), with EPS at Rs. 0.9 vs Rs. 1.2 earlier. The company recently commissioned a 158-bed multi-specialty hospital in Raipur under an asset-light model (Rs. 55 crore investment) and signed an MoU for a 150-bed hospital in Jamshedpur (~Rs. 74 crore, expected by end of FY27). It now operates 5 hospitals with over 719 beds across eastern India under the ILS Hospitals brand, with a stated goal of becoming a 1,000-bed chain in 2–3 years.
Mixed quarter for shareholders — topline growth is healthy but margin compression and a ~22% drop in net profit may weigh on the stock in the short term. The aggressive expansion pipeline (Raipur live, Jamshedpur in pipeline) supports future revenue growth but raises near-term capex and execution risks.